After restricting the analysis to intrinsic molecular breast cancer subtypes, we found that high Notch3 expression had a better prognosis for those with the luminal A, luminal B subtype compared to those with low Notch3 expression (Fig. 6b, c). The gene discussed is NOTCH3; the disease is breast cancer.